Patents/Assignees

Bioxcel Therapeutics, Inc.

12 patents in portfolio

US12364683utility2025
Non-sedating Dexmedetomidine Treatment Regimens
0 cites
US12138247utility2024
Non-sedating Dexmedetomidine Treatment Regimens
0 cites
US12109196utility2024
Non-sedating Dexmedetomidine Treatment Regimens
0 cites
US12090140utility2024
Non-sedating Dexmedetomidine Treatment Regimens
0 cites
US11998528utility2024
Non-sedating Dexmedetomidine Treatment Regimens
0 cites
US11998529utility2024
Non-sedating Dexmedetomidine Treatment Regimens
0 cites
US11931340utility2024
Use of Sublingual Dexmedetomidine for the Treatment of Agitation
0 cites
US11890272utility2024
Non-sedating Dexmedetomidine Treatment Regimens
0 cites
US11839604utility2023
Use of Sublingual Dexmedetomidine for the Treatment of Agitation
0 cites
US11806334utility2023
Non-sedating Dexmedetomidine Treatment Regimens
0 cites
US11806429utility2023
Film Formulations Containing Dexmedetomidine and Methods of Producing Them
0 cites
US11786508utility2023
Use of Sublingual Dexmedetomidine for the Treatment of Agitation
0 cites